Quantitation of platelet-derived growth factor receptors in human arterial smooth muscle cells in vitro

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 2395-2404

  Krettek, Alexandra ^a   Fager, Gunnar ^a   Jernberg, Peter ^a   Östergren Lundén, Gunnel ^a   Lustig, Florentyna ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cell proliferation; PDGF; PDGF receptor; Smooth muscle cell

Indexed keywords

PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ARTERY MEDIA; ARTICLE; ATHEROGENESIS; CELL PROLIFERATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS REGULATION; RECEPTOR DENSITY; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0031470513     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.2395     Document Type: Article

References (20)

1. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 1991;253:1129-1132.
2. Nabel EG, Yang Z, Liptay S, San H, Gordon D, Haudenschild CC, Nabel GJ. Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimal hyperplasia in vivo. J Clin Invest. 1993;91:1822-1829.
3. Fager G, Camejo G, Bondjers G. Heparin-like glycosaminoglycans influence growth and phenotype of human arterial smooth muscle cells in vitro. I. Evidence for reversible binding and inactivation of the platelet-derived growth factor by heparin. In Vitro Cell Dev Biol. 1992;28A:168-175.
4. Lustig F, Hoebeke J, Östergren-Lundén G, Velge-Roussel F, Bondjers G, Olsson U, Rüctschi U, Fager G. Alternative splicing determines the binding of platelet-derived growth factor (PDGF-AA) to glycosaminoglycans. Biochemistry. 1996;35:12077-12085.
5. LaRochelle WJ, May-Siroff M, Robbins KC, Aaronson SA. A novel mechanism regulating growth factor association with the cell surface: identification of a PDGF retention domain. Genes Dev. 1991;5:1191-1199.
6. Herren B, Rooney B, Weyer KA, Iberg N, Schmid G, Pech M. Dimerization of extracellular domains of platelet-derived growth factor receptors: a revised model of receptor-ligand interaction. J Biol Chem. 1993;268:15088-15095.
7. Hanks SK, Quinn AM, Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science. 1988;241:42-52.
8. Heidaran MA, Yu J-C, Jensen RA, Pierce JH, Aaronson SA. A deletion in the extracellular domain of the α platelet-derived growth factor (PDGF) receptor differentially impairs PDGF-AA and PDGF-BB binding affinities. J Biol Chem. 1992;267:2884-2887.
9. Clements JM, Bawden LJ, Bloxidge RE, Catlin G, Cook AL, Craig S, Drummond AH, Edwards RM, Fallon A, Green DR, Hellewell PG, Kirwin PM, Nayee PD, Richardson SJ, Brown D, Chahwala SB, Snarey M, Winslow D. Two PDGF-B chain residues, arginine 27 and isoleucine 30, mediate receptor binding and activation. EMBO J. 1991;10:4113-4120.
10. Jaumann M, Hoppe V, Tatje D, Eichner W, Hoppe J. On, the structure of platelet-derived growth factor AA: C-terminal processing, epitopes, and characterization of cysteine residues. Biochemistry. 1991;30:3303-3309.
11. Andersson M, Ostman A, Kreysing J, Bäckström G, Van de Poll M, Heldin C-H. Involvement of loop 2 of platelet-derived growth factor-AA and -BB in receptor binding. Growth Factors. 1995;12:159-164.
12. Bornfeldt KE, Raines EW, Graves LM, Skinner MP, Krebs EG, Ross R. Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation. Ann N Y Acad Sci. 1995;766:416-430.
13. Hosang M, and Rouge M. Human vascular smooth muscle cells have at least two distinct PDGF receptors and can secrete PDGF-AA. J Cardiovasc Pharmacol. 1989;14:S22-S26.
14. Ferns GAA, Sprugel KH, Seifert RA, Bowen-Pope DF, Kelly JD, Murray M, Raines EW, Ross R. Relative platelet-derived growth factor receptor subunit expression determines cell migration to different dimeric forms of PDGF. Growth Factors. 1990;3:315-324.
15. Afink GB, Nistér M, Stassen BHGJ, Joosten PHLJ, Rademakers PJH, Bongcam-Rudloff E, Van Zoelen EJJ, Mosselman S. Molecular cloning and functional characterization of the human platelet-derived growth factor α receptor gene promoter. Oncogene. 1995;10:1667-1672.
16. Kraft HJ, Mosselman S, Smits HA, Hohenstein P, Piek E, Chen Q, Artzt K, Van Zoelen EJJ. Oct-4 regulates alternative platelet-derived growth factor α receptor gene promoter in human embryonal carcinoma cells. J Biol Chem. 1996;271:12873-12878.
17. Vu TH, Martin GR, Lee P, Mark D, Wang A, Williams LT. Developmentally regulated use of alternative promoters creates a novel platelet-derived growth factor receptor transcript in mouse teratocarcinoma and embryonic stem cells. Mol Cell Biol. 1989;9:4563-4567.
18. Fager G, Hansson GK, Ottosson P, Dahllöf B, Bondjers G. Human Arterial Smooth Muscle Cells in Culture. Effects of platelet-derived growth factor and heparin on growth in vitro. Exp Cell Res. 1988;176: 319-335.
19. Chirgwin JM, Przybyla AM, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979;18:5294-5298.
20. Wang AM, Doyle MV, Mark DF. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA. 1989;86:9717-9721.